b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29082495</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>06</Month>\n            <Day>19</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1940-6029</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>1683</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Methods in molecular biology (Clifton, N.J.)</Title>\n                <ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>211-227</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-7357-6_13</ELocationID>\n            <Abstract>\n                <AbstractText>Transcriptional Intermediary Factor 2 (TIF2) is a key Androgen receptor (AR) coactivator that has been implicated in the development and progression of castration resistant prostate cancer (CRPC). This chapter describes the implementation of an AR-TIF2 protein-protein interaction (PPI) biosensor assay to screen for small molecules that can induce AR-TIF2 PPIs, inhibit the DHT-induced formation of AR-TIF2 PPIs, or disrupt pre-existing AR-TIF2 PPIs. The biosensor assay employs high content imaging and analysis to quantify AR-TIF2 PPIs and integrates physiologically relevant cell-based assays with the specificity of binding assays by incorporating structural information from AR and TIF2 functional domains along with intracellular targeting sequences using fluorescent protein reporters. Expression of the AR-Red Fluorescent Protein (RFP) &quot;prey&quot; and TIF2-Green Fluorescent Protein (GFP) &quot;bait&quot; components of the biosensor is directed by recombinant adenovirus (rAV) expression constructs that facilitated a simple co-infection protocol to produce homogeneous expression of both biosensors that is scalable for screening. In untreated cells, AR-RFP expression is localized predominantly to the cytoplasm and TIF2-GFP expression is localized only in the nucleoli of the nucleus. Exposure to DHT induces the co-localization of AR-RFP within the TIF2-GFP positive nucleoli of the nucleus. The AR-TIF2 biosensor assay therefore recapitulates the ligand-induced translocation of latent AR from the cytoplasm to the nucleus, and the PPIs between AR and TIF2 result in the colocalization of AR-RFP within TIF2-GFP expressing nucleoli. The AR-TIF2 PPI biosensor approach offers significant promise for identifying molecules with potential to modulate AR transcriptional activity in a cell-specific manner that may overcome the development of resistance and progression to CRPC.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Hua</LastName>\n                    <ForeName>Yun</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Room 586 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Camarco</LastName>\n                    <ForeName>Daniel P</ForeName>\n                    <Initials>DP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Room 586 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Strock</LastName>\n                    <ForeName>Christopher J</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Cyprotex US, 313 Pleasant Street, Watertown, MA, 02472, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Johnston</LastName>\n                    <ForeName>Paul A</ForeName>\n                    <Initials>PA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Room 586 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA. paj18@pitt.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>R01 CA160423</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 CA183882</GrantID>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R21 NS073889</GrantID>\n                    <Acronym>NS</Acronym>\n                    <Agency>NINDS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Methods Mol Biol</MedlineTA>\n            <NlmUniqueID>9214969</NlmUniqueID>\n            <ISSNLinking>1064-3745</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D051958">Nuclear Receptor Coactivator 2</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="ErratumIn">\n                <RefSource>Methods Mol Biol. 2018;1683:E1</RefSource>\n                <PMID Version="1">29256175</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D015374" MajorTopicYN="Y">Biosensing Techniques</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055808" MajorTopicYN="Y">Drug Discovery</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057166" MajorTopicYN="Y">High-Throughput Screening Assays</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057054" MajorTopicYN="N">Molecular Imaging</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051958" MajorTopicYN="N">Nuclear Receptor Coactivator 2</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D025941" MajorTopicYN="N">Protein Interaction Mapping</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">High content screening</Keyword>\n            <Keyword MajorTopicYN="Y">Image analysis</Keyword>\n            <Keyword MajorTopicYN="Y">Imaging</Keyword>\n            <Keyword MajorTopicYN="Y">Protein-protein interaction biosensors</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29082495</ArticleId>\n            <ArticleId IdType="doi">10.1007/978-1-4939-7357-6_13</ArticleId>\n            <ArticleId IdType="pmc">PMC6753931</ArticleId>\n            <ArticleId IdType="mid">NIHMS1049377</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Urol Res. 2000 Aug;28(4):211-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11011957</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2001 Apr 1;61(7):2892-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11306464</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2002 Feb 22;108(4):465-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11909518</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocrinology. 2002 Jul;143(7):2461-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12072374</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Methods Mol Biol. 2002;183:181-98</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12136753</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2002 Sep;9(3):155-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12237244</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Endocrinol. 2003 Sep;17(9):1681-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12805412</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Chem Biol. 2004 Aug;8(4):442-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15288255</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Sci. 2005 Jan;83(1):136-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15483189</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2005 Jul 1;115(4):630-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15700310</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Traffic. 2005 Jul;6(7):594-606</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15941410</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anal Chem. 2005 Aug 1;77(15):4815-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16053293</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Endocrinol. 2006 Feb 26;246(1-2):147-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16388893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Med (Berl). 2006 Nov;84(11):919-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16932916</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2006 Nov 1;66(21):10594-602</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17079484</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Methods Enzymol. 2006;414:364-89</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17110203</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Methods Enzymol. 2006;414:389-418</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17110204</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Methods Enzymol. 2006;414:419-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17110205</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2006 Dec;13(4):979-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17158750</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2007 Feb 15;120(4):719-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17163421</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Invest. 2007 Feb;25(1):32-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17364555</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2007 Dec 13;450(7172):1001-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18075579</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Plant J. 2008 Feb;53(4):610-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18269572</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Discov Technol. 2008 Sep;5(3):190-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18690888</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prostate. 2008 Dec 1;68(16):1816-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18780293</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuropsychopharmacology. 2009 Jan;34(1):247-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19079071</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2009 Mar;8(3):665-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19240160</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Methods Mol Biol. 2009;565:159-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19551362</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Physiol. 2010;72:247-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20148675</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prostate. 2010 Jun 15;70(9):959-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20166126</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Chem Biol. 2010 Jun;14(3):331-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20395165</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biomol Screen. 2010 Aug;15(7):766-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20639499</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Assay Drug Dev Technol. 2010 Aug;8(4):437-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20662736</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>World J Urol. 2012 Jun;30(3):297-302</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22105110</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Assay Drug Dev Technol. 2012 Oct;10(5):432-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22830992</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Biochem Cell Biol. 2013 Apr;45(4):763-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23270728</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Steroids. 2013 Sep;78(9):851-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23643785</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Assay Drug Dev Technol. 2014 Jan-Feb;12(1):55-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24127660</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Assay Drug Dev Technol. 2014 Sep;12(7):395-418</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25181412</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 1988 May 13;240(4854):889-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3283939</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Virology. 1998 Nov 10;251(1):38-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9813201</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'